In a major change in access to oral contraception, the Food and Drug Administration has approved a birth control pill that will be available without a prescription.

“It could be huge,” said Yasaswi Kislovskiy, director of reproductive infectious disease for Allegheny Health Network. “The hope is that this reduces barriers for people who know they don’t want to be pregnant to get the medication to reduce the chance of getting pregnant.”

The medication, called Opill, will be available online and at retail stores in the first quarter of 2024, according to the manufacturer, Perrigo. It will be the first daily, over-the-counter birth control pill available in the U.S.

The FDA approval “is a groundbreaking expansion for women’s health in the U.S. and a significant milestone towards addressing a key unmet need for contraceptive access,” said Frederique Welgryn, Perrigo global vice president for women’s health, in a Thursday news release.

Advertise with us

Opill contains the hormone norgestrel, which was originally approved by the FDA for contraceptive use in 1973 as a prescription medication. Perrigo applied a year ago to switch the medication from prescription to over-the-counter, and the FDA evaluated it to see whether consumers could use it safely and effectively, without assistance from a health care professional.

“Studies showed that consumer understanding of information on the Opill Drug Facts label with high overall and that a high proportion of consumers understood the label instructions, supporting their ability to properly use the drug when it is available as an over-the-counter product,” said the FDA in a Thursday news release. “When property used, Opill is safe and effective.”

Almost half of the 6.1 million pregnancies in the United States every year are unintended, according to the FDA.

The approval of Opill is expected to expand access for those who do not want to or cannot make or wait for a doctor’s appointment. Opill is approved without a prescription for users of any age.

“We still have lots of data showing that people have barriers to getting a prescription for birth control,” said Dr. Kislovskiy, who is also the co-director of AHN’s Perinatal Hope Program, which treats mothers and pregnant women with substance use disorders. “If we can take that step away, it could have a beautiful impact on people’s pregnancies that they don’t want to have.”

Advertise with us

What access to Opill will actually look like inside a pharmacy or grocery store is still unknown, said Dr. Kislovskiy. Studies have shown that even though emergency contraceptive pills, such as Plan B, are approved for use without a prescription, not all pharmacies carry them and some still impose age restrictions or keep it locked up or behind the pharmacy counter.

“My hope is that it’s going to be easy,” Dr. Kislovskiy said. “If you are a person who doesn’t want to be pregnant, you pick it up in the medication aisle and walk out the door.”

Opill should be taken at the same time every day to be most effective, said the FDA. When taken “in perfect use,” the medication is 98% effective in preventing pregnancies, said Dr. Kislovskiy. With typical use — inconsistent or incorrect use — it drops down to 80% or 90%, she said.

The medication should not be taken by anyone with a history of breast cancer, and those with any history of cancer should consult their doctor, according to the FDA. It also should not be used together with any other form of hormonal birth control.

The most common side effects include irregular bleeding, headaches, dizziness, nausea, increased appetite, abdominal pain, cramps or bleeding.

Advertise with us

Opill is not an emergency contraceptive, said the FDA, and does not prevent pregnancy after unprotected sex.

The timing of the approval could be fortuitous in terms of preventing unwanted pregnancies, given the Supreme Court’s Dobbs vs. Jackson’s Women’s Health Organization ruling last June, which has limited or eliminated abortions in some states, said Dr. Kislovskiy, noting that she was giving her own opinion on the subject and not speaking for AHN.

“Speaking for myself, after seeing abortion access restricted, this is a really resounding sign, hopefully, that we are putting that power back in the hands of our patients,” she said.

Anya Sostek: asostek@post-gazette.com